Specializing in providing nuclear medicine services

including the development, production and supply of diagnostic and therapeutic radiopharmaceuticals and radioisotopes.

Specializing in providing nuclear medicine services

including the development, production and supply of diagnostic and therapeutic radiopharmaceuticals and radioisotopes.

Specializing in providing nuclear medicine services

including the development, production and supply of diagnostic and therapeutic radiopharmaceuticals and radioisotopes.

Cutting-edge technology in the fight against cancer

Radioisotopes and Generators

Relying on a global supply chain system, we can consistently to provide stable and reliable radioisotopes. At the same time, we have developed a variety of new nuclide generators, which can effectively alleviate the supply shortage of short half-life radioisotopes in the market.

Cutting-edge technology in the fight against cancer

Radioisotopes and Generators

Next Generation Radiopharmaceuticals

We are developing a series of molecularly targeted products for the diagnosis and treatment of cancer, that will redefine the next generation of radiopharmaceuticals based on product and technology innovations.

Want to know how United Well supports your research and development of radiopharmaceuticals?

News Center

View all news

United Well had a high-level clinical and scientific talk with experts on EANM’24

The 37th Annual Congress of the European Association of Nuclear Medicine (EANM’24) was held in Hamburg, Germany on October 19-23, 2024.

Hot Spots and Abstract Review of 2024 Suzhou Symposium

Sep 30,2024

The Scientific Development and Clinical Transformation of Radiopharmaceuticals 2024 Suzhou Symposium was held successfully on September 23, 2024.

Congratulations on the Grand Opening of the 9th International Symposium on Space Radiation Research and Particle Radiotherapy

Sep 30,2024

On September 22, the 9th International Symposium on Space Radiation Research and Particle Radiotherapy (ISSPRPT2024) was held in Kunshan. This symposium was hosted by the School of Radiomedicine and Protection

Congratulations on the Success of 2024 Annual Conference of Chinese Society of Nuclear Medicine

Sep 14,2024

PET can predict MACE in cardiac sarcoidosis patients

Aug 13,2024

PET tracer performs well in prostate cancer trial

Aug 13,2024

PET/MRI rules out tau protein in late-life depression Will Morton

Aug 12,2024

Tau PET identifies grey matter atrophy in retired athletes

Aug 12,2024

Study explores neurologic problems in Pluvicto patients

Aug 09,2024